NFL Legend Tom Brady Facing Criticism for Controversial Decision
Summary
Tom Brady announced that he cloned his late dog, Lua, using biotech company Colossal Biosciences' cloning technology. Brady, who is an investor in the company, faced mixed reactions from the media about his decision to clone the pet.Key Facts
- Tom Brady announced he cloned his late dog, Lua, with the help of Colossal Biosciences.
- Lua was cloned using blood collected before it died in December 2023.
- Brady worked with Colossal Biosciences, a company where he is an investor.
- Colossal Biosciences recently acquired another biotech company, Viagen Pets and Equine.
- Brady mentioned the cloning could help families who miss their pets and aid in saving endangered species.
- The announcement received varied reactions from media personalities.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.